Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) announced interim results from its ongoing Phase 2/3 study of QRX003 4% lotion in patients ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE